T 150 (Tarceva 150 mg)

Generic Name: erlotinib

Pill imprint T 150 has been identified as Tarceva 150 mg.

Tarceva is used in the treatment of non-small cell lung cancer; renal cell carcinoma; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for T 150 (Tarceva 150 mg)

Tarceva 150 mg T 150
Tarceva
Generic Name:
erlotinib
Imprint:
T 150
Strength:
150 mg
Color:
White
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Genentech
National Drug Code (NDC):
50242-0064
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5447 Physicians Total Care Inc (repackager)
54569-5848 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web4)